NCBP2 and mesothelioma: In contrast, the expression of NCBP2 was lower in kidney renal clear cell carcinoma (KIRC), adrenocortical carcinoma (ACC), acute myeloid leukemia (LAML) (expression data for mesothelioma (MESO), pheochromocytoma and paraganglioma (PCPG), sarcoma (SARC) and uveal melanoma (UVM) were not shown for the absence of enough control normal tissue data) (Fig. 2A).